ATHA - Athira Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ATHA is currently covered by 3 analysts with an average potential upside of $11.87 (200.69%) from yesterday's end of day stock price of $1.96. Athira Pharma activity chart has currently 2 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Highest price target for ATHA is $13, Lowest price target is $2, average price target is $7.5.

Most recent stock forecast was given by JASON BUTLER from JMP on 11-Aug-2023. First documented stock forecast 21-Dec-2020.

Currently, out of the existing stock ratings of ATHA - 4 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

19

$16.98 (840.59%)

3 months 29 days ago

0/1 (0%)

$16.19 (576.16%)

Buy

5

$3.04 (155.10%)

6 months 25 days ago

0/1 (0%)

$2.13 (74.22%)

Buy

10

$8.39 (521.12%)

33

8 months 10 days ago

0/2 (0%)

$15.64 (281.25%)

Buy

36

1 years 5 months 18 days ago

0/1 (0%)

$24.4 (210.34%)

Buy

1 years 11 months 5 days ago

0/1 (0%)

$8.79 (28.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATHA (Athira Pharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ATHA (Athira Pharma) with a proven track record?

ANDREW TSAI

Which analyst has the current lower performing score on ATHA (Athira Pharma) with a proven track record?

THOMAS SHRADER

Which analyst has the most public recommendations on ATHA (Athira Pharma)?

Andrew Tsai works at JEFFERIES and has 3 price targets and 2 ratings on ATHA

Which analyst is the currently most bullish on ATHA (Athira Pharma)?

Jason Butler with highest potential upside - $16.98

Which analyst is the currently most reserved on ATHA (Athira Pharma)?

Andrew Tsai with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart